Special Drug-Use Results Survey of IMBRUVICA Capsules 140 mg (relapsed or refractory mantle cell lymphoma [MCL])
Latest Information Update: 20 Oct 2017
At a glance
- Drugs Ibrutinib (Primary)
- Indications Mantle-cell lymphoma
- Focus Adverse reactions
- Sponsors Janssen Pharmaceutical KK
- 10 Jul 2017 New trial record